Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment

Harm Reduction Journal

Volumn 9, Issue , 2012, Pages

  Marchand, Kirsten ^a   Oviedo Joekes, Eugenia ^a,b   Guh, Daphne ^a   Marsh, David C ^c,d   Brissette, Suzanne ^e   Schechter, Martin T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

^d NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Opioid dependence; Sex work; Substitution treatment

Indexed keywords

DIAMORPHINE; HYDROMORPHONE; METHADONE;

ACADEMIC ACHIEVEMENT; ARTICLE; CANADA; COCAINE DEPENDENCE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH STATUS; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; OPEN STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTITUTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL BEHAVIOR; SYMPTOM;

EID: 84856084686     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-9-8     Document Type: Article

References (44)

1. Kuyper LM, Hogg RS, Montaner JSG, Schechter MT, Wood E. The Cost of Inaction on Hiv Transmission Among Injection Drug Users and the Potential for Effective Interventions. Journal of Urban Health-Bulletin of the New York Academy of Medicine 2004, 81:655-660. 10.1093/jurban/jth148, 15466846.
2. Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008, CD004145.
3. March JC, Oviedo-Joekes E, Romero M. Drugs and social exclusion in ten European cities. Eur Addict Res 2006, 12:33-41. 10.1159/000088581, 16352901.
4. Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care 2003, 15:187-95. 10.1080/0954012031000068335, 12856340.
5. Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-Burkitt B, Schechter MT, Spittal PM. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Int J Drug Policy 2008, 19:159-68. 10.1016/j.drugpo.2007.07.005, 17870461.
6. Chettiar J, Shannon K, Wood E, Zhang R, Kerr T. Survival sex work involvement among street-involved youth who use drugs in a Canadian setting. J Public Health (Oxf) 2010, 32:322-7.
7. Shannon K, Bright V, Gibson K, Tyndall MW. Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada. Can J Public Health 2007, 98:465-9.
8. Eiroa-Orosa FJ, Verthein U, Kuhn S, Lindemann C, Karow A, Haasen C, Reimer J. Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial. Am J Addict 2010, 19:312-8.
9. Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, Schechter MT. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. Drug Alcohol Depend 2010,
10. Paone D, Cooper H, Alperen J, Shi Q, Des Jarlais DC. HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities. AIDS Care 1999, 11:269-80. 10.1080/09540129947910, 10474627.
11. Kuyper LM, Palepu A, Kerr T, Li K, Miller CL, Spittal PM, Hogg RS, Montaner JSG, Wood E. Factors Associated With Sex-Trade Involvement Among Female Injection Drug Users in a Canadian Setting. Addiction Research & Theory 2005, 13:193-199. 10.1080/16066350500053349, 22287960.
12. El-Bassel N, Simoni JM, Cooper DK, Gilbert L, Schilling RF. Sex trading and psychological distress among women on methadone. Psychol Addict Behav 2001, 15:177-84.
13. Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E. Binge Drug Use Independently Predicts HIV Seroconversion Among Injection Drug Users: Implications for Public Health Strategies. Subst Use Misuse 2006, 41:199-210. 10.1080/10826080500391795, 16393742.
14. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994, 84:382-7. 10.2105/AJPH.84.3.382, 1614821, 8129052.
15. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001, 357:1397-401. 10.1016/S0140-6736(00)04562-1, 11356437.
16. Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr 2002, 30:335-41.
17. Gu J, Lau JT, Chen H, Tsui H, Ling W. Prevalence and factors related to syringe sharing behaviours among female injecting drug users who are also sex workers in China. Int J Drug Policy 2010,
18. Haasen C, van den Brink W. Innovations in agonist maintenance treatment of opioid-dependent patients. Curr Opin Psychiatry 2006, 19:631-636. 10.1097/01.yco.0000245759.13997.9d, 17012944.
19. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-6. 10.1016/S0140-6736(98)05356-2, 9923893.
20. Amato L, Davoli M, A Perucci C, Ferri M, Faggiano F, P Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005, 28:321-9. 10.1016/j.jsat.2005.02.007, 15925266.
21. Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag 2006, 2:35-41.
22. Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005, 80:329-35. 10.1016/j.drugalcdep.2005.05.002, 15964714.
23. Perreault M, Rousseau M, Lauzon P, Mercier C, Tremblay I, Héroux M. Determinants of Retention in a Canadian Low-Threshold Methadone Maintenance Program. Journal of Maintenance in the Addictions 2007, 3:37-51.
24. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009, 361:777-86. 10.1056/NEJMoa0810635, 19692689.
25. Oviedo-Joekes E, Nosyk B, Marsh D, Guh D, Brissette S, Gartry C, Krausz M, Anis A, Schechter MT. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI Study. Clinical Trials 2009, 6:261-271. 10.1177/1740774509105222, 19528135.
26. Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT. The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America's First Trial of Heroin-Assisted Treatment. J Urban Health 2008, 85:812-25. 10.1007/s11524-008-9312-9, 2587648, 18758964.
27. Health Canada Best practices in methadone maintenance treatment. 2002, Ontario, Canada.: Minister of Public Works and Government Services Canada.
28. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research 1995, 1:208-210.
29. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998, 93:1857-67. 10.1046/j.1360-0443.1998.9312185711.x, 9926574.
30. van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend 2006, 82:111-8. 10.1016/j.drugalcdep.2005.08.012, 16168573.
31. Jarrin I, Lumbreras B, Ferreros I, Perez-Hoyos S, Hurtado I, Hernandez-Aguado I. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. Int J Epidemiol 2007, 36:187-94.
32. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol 2003, 158:695-704. 10.1093/aje/kwg209, 14507606.
33. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001, 58:503-8. 10.1001/archpsyc.58.5.503, 11343531.
34. Acharyya S, Zhang H. Assessing sex differences on treatment effectiveness from the drug abuse treatment outcome study (DATOS). Am J Drug Alcohol Abuse 2003, 29:415-44. 10.1081/ADA-120020524, 12765214.
35. Stewart D, Gossop M, Marsden J, Kidd T, Treacy S. Similarities in outcomes for men and women after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). Drug Alcohol Rev 2003, 22:35-41. 10.1080/0959523021000059811, 12745357.
36. Gilchrist G, Gruer L, Atkinson J. Comparison of drug use and psychiatric morbidity between prostitute and non-prostitute female drug users in Glasgow, Scotland. Addict Behav 2005, 30:1019-23. 10.1016/j.addbeh.2004.09.003, 15893098.
37. El-Bassel N, Witte SS, Wada T, Gilbert L, Wallace J. Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, HIV risks. AIDS Patient Care STDS 2001, 15:41-51. 10.1089/108729101460092, 11177587.
38. Stoltz JA, Shannon K, Kerr T, Zhang R, Montaner JS, Wood E. Associations between childhood maltreatment and sex work in a cohort of drug-using youth. Soc Sci Med 2007, 65:1214-21. 10.1016/j.socscimed.2007.05.005, 2254224, 17576029.
39. Charney DA, Palacios-Boix J, Gill KJ. Sexual abuse and the outcome of addiction treatment. Am J Addict 2007, 16:93-100. 10.1080/10550490601184225, 17453610.
40. Kang SY, Deren S, Goldstein MF. Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs. Child Abuse Negl 2002, 26:1275-89. 10.1016/S0145-2134(02)00412-X, 12464301.
41. Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR. Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes. Drug Alcohol Depend 2005, 78:57-64. 10.1016/j.drugalcdep.2004.09.005, 15769558.
42. Tiet QQ, Finney JW, Moos RH. Recent sexual abuse, physical abuse, suicide attempts among male veterans seeking psychiatric treatment. Psychiatr Serv 2006, 57:107-13. 10.1176/appi.ps.57.1.107, 16399970.
43. Langeland W, Draijer N, van den Brink W. Assessment of lifetime physical and sexual abuse in treated alcoholics. Validity of the Addiction Severity Index. Addict Behav 2003, 28:871-81. 10.1016/S0306-4603(01)00297-0, 12788262.
44. Najavits LM, Weiss RD, Reif S, Gastfriend DR, Siqueland L, Barber JP, Butler SF, Thase M, Blaine J. The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder. J Stud Alcohol 1998, 59:56-62.